NS
Navin Satyapal Saxena
About Navin Satyapal Saxena
Data last updated:
Navin Satyapal Saxena is a Director at Rusan Pharma Limited (since 1994), Director at Rusan Health Care Private Limited (since 1999) and Director at Navin Saxena Research And Technology Private Limited (since 1994), and holds 5 more current directorships. The companies operate in Pharma, Healthcare and Financial Services. The 8 current companies with reported revenue have a combined latest revenue of ₹440 Cr; the largest is Rusan Pharma Limited at ₹392 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Mar 1994 | 1994 | ₹392 Cr (FY 2025) | Active | |
| Director | 03 Nov 1999 | 1999 | ₹31.60 Cr (FY 2024) | Active | |
| Director | 23 Nov 1994 | 1994 | ₹13.34 Cr (FY 2025) | Active | |
| Director | 08 Aug 2014 | 2014 | ₹1.56 Cr (FY 2025) | Active | |
| Director | 03 May 2011 | 2011 | ₹62.6 Lakh (FY 2024) | Active | |
| Director | 17 Oct 2012 | 1994 | ₹26.9 Lakh (FY 2025) | Active | |
| Director | 06 Sep 2022 | 2022 | ₹5 Lakh (FY 2025) | Active | |
| Director | 23 Jan 1998 | 1998 | ₹1.6 Lakh (FY 2024) | Active |
Board colleagues of Navin Satyapal Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aakarsh Navin Saxena | 07432845 | Rusan Pharma Limited , Navin Saxena Research And Technology Private Limited | Whole-Time Director |
| Balasaheb Annasaheb Patil | 00143017 | Rusan Pharma Limited , Rusan Health Care Private Limited and 1 more | Whole-Time Director |
| Kunal Navin Saxena | 05267911 | Rusan Pharma Limited , Rusan Health Care Private Limited and 6 more | Managing Director |
| Sandeep Verma | 07212506 | Rusan Pharma Limited | Director |
| Ashok Chaturbhuj Sharma | 06575382 | Rusan Health Care Private Limited , Tuscany Holdings Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navin Satyapal Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navin Satyapal Saxena
Navin Satyapal Saxena currently holds 8 directorships: Rusan Pharma Limited (Director, since 15 Mar 1994, revenue ₹392 Cr (FY 2025)); Rusan Health Care Private Limited (Director, since 03 Nov 1999, revenue ₹31.60 Cr (FY 2024)); Navin Saxena Research And Technology Private Limited (Director, since 23 Nov 1994, revenue ₹13.34 Cr (FY 2025)); Quantys Clinical Private Limited (Director, since 08 Aug 2014, revenue ₹1.56 Cr (FY 2025)); Navicare Pharma Private Limited (Director, since 03 May 2011, revenue ₹62.6 Lakh (FY 2024)); and 3 more.
Navin Satyapal Saxena was first appointed on 15 Mar 1994 as Director at Rusan Pharma Limited. The most recent appointment on record is 06 Sep 2022 at Ru-Tech Design Masters Private Limited.
The 8 current companies of Navin Satyapal Saxena that report revenue have a combined latest revenue of ₹440 Cr: Rusan Pharma Limited ₹392 Cr (FY 2025); Rusan Health Care Private Limited ₹31.60 Cr (FY 2024); Navin Saxena Research And Technology Private Limited ₹13.34 Cr (FY 2025); Quantys Clinical Private Limited ₹1.56 Cr (FY 2025); Navicare Pharma Private Limited ₹62.6 Lakh (FY 2024); and 3 more.
The current boards of Navin Satyapal Saxena's companies include Aakarsh Navin Saxena (Rusan Pharma Limited), Balasaheb Annasaheb Patil (Rusan Pharma Limited), Kunal Navin Saxena (Rusan Pharma Limited), Sandeep Verma (Rusan Pharma Limited), Ashok Chaturbhuj Sharma (Rusan Health Care Private Limited).